The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.
Level 5 - mechanism / opinion, no new human data
Narrative mechanistic review without systematic methodology or primary human data
PubMed 36516892 · doi:10.1016/j.neuropharm.2022.109376
What was done
This is a narrative review synthesizing literature on endogenous opioid peptide regulation and its translational relevance to alcohol use disorder. The authors summarized known and hypothesized synthesis pathways for over two dozen high-affinity endogenous peptides (particularly endomorphins), evaluated neural circuit expression and compartmentalized release dynamics across brain regions, reviewed stimulation thresholds and extracellular diffusion lifetimes, and examined mechanistic literature regarding how the non-specific antagonist naltrexone blocks endogenous opioid activity in alcohol use disorder.
What was found
The abstract reports no quantitative values, effect sizes, or trial results. It qualitatively outlines synthesis routes, region-specific release profiles, diffusion parameters of endogenous peptides, and the precise signaling mechanisms inhibited by naltrexone.
Why it matters
Understanding the spatiotemporal dynamics and release properties of endogenous opioid peptides helps clarify how broad-spectrum antagonists like naltrexone work clinically and highlights opportunities for developing more targeted therapeutics for neuropsychiatric and substance use disorders.
Limits
As a narrative review, this work does not provide systematic search methods, quantitative synthesis, or original clinical data. The abstract provides no numerical findings or sample sizes, and much of the mechanistic evidence regarding peptide release and diffusion relies on preclinical animal or in vitro models that may not fully translate to humans.
Cited by
- supports Alcohol acts upon the endogenous opioid system in the brain.